These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 26558524)

  • 1. Neoadjuvant Systemic Therapy Before Radical Prostatectomy in High-Risk Prostate Cancer Does Not Increase Surgical Morbidity: Contemporary Results Using the Clavien System.
    Williams SB; Davis JW; Wang X; Achim MF; Zurita-Saavedra A; Matin SF; Pisters LL; Ward JF; Pettaway CA; Chapin BF
    Clin Genitourin Cancer; 2016 Apr; 14(2):130-8. PubMed ID: 26558524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A genomic classifier improves prediction of metastatic disease within 5 years after surgery in node-negative high-risk prostate cancer patients managed by radical prostatectomy without adjuvant therapy.
    Klein EA; Yousefi K; Haddad Z; Choeurng V; Buerki C; Stephenson AJ; Li J; Kattan MW; Magi-Galluzzi C; Davicioni E
    Eur Urol; 2015 Apr; 67(4):778-86. PubMed ID: 25466945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radical Prostatectomy With and Without Neoadjuvant Chemohormonal Pretreatment for High-Risk Localized Prostate Cancer: A Comparative Propensity Score Matched Analysis.
    Narita S; Nara T; Kanda S; Numakura K; Saito M; Inoue T; Satoh S; Nanjo H; Tsuchiya N; Mitsuzuka K; Koie T; Kawamura S; Ohyama C; Tochigi T; Arai Y; Habuchi T
    Clin Genitourin Cancer; 2019 Feb; 17(1):e113-e122. PubMed ID: 30391137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Standardized comparison of robot-assisted limited and extended pelvic lymphadenectomy for prostate cancer.
    Yuh BE; Ruel NH; Mejia R; Novara G; Wilson TG
    BJU Int; 2013 Jul; 112(1):81-8. PubMed ID: 23351148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Standardized report for early complications of radical prostatectomy.
    Cheng WM; Lin TP; Lin CC; Huang EY; Chung HJ; Kuo JY; Huang WJ; Chang YH; Lin AT; Chen KK
    J Chin Med Assoc; 2014 May; 77(5):234-41. PubMed ID: 24767582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association of age with perioperative morbidity and mortality among men undergoing radical prostatectomy.
    Pereira JF; Golijanin D; Pareek G; Guo R; Zhang Z; Renzulli J; Gershman M D B
    Urol Oncol; 2018 Apr; 36(4):157.e7-157.e13. PubMed ID: 29273350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome.
    Ward JF; Slezak JM; Blute ML; Bergstralh EJ; Zincke H
    BJU Int; 2005 Apr; 95(6):751-6. PubMed ID: 15794776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Standardized analysis of frequency and severity of complications after robot-assisted radical cystectomy.
    Yuh BE; Nazmy M; Ruel NH; Jankowski JT; Menchaca AR; Torrey RR; Linehan JA; Lau CS; Chan KG; Wilson TG
    Eur Urol; 2012 Nov; 62(5):806-13. PubMed ID: 22705382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II trial of neoadjuvant docetaxel and gefitinib followed by radical prostatectomy in patients with high-risk, locally advanced prostate cancer.
    Vuky J; Porter C; Isacson C; Vaughan M; Kozlowski P; Picozzi V; Corman J
    Cancer; 2009 Feb; 115(4):784-91. PubMed ID: 19130458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population-based analysis of salvage radical prostatectomy with examination of factors associated with adverse perioperative outcomes.
    Pearce SM; Richards KA; Patel SG; Pariser JJ; Eggener SE
    Urol Oncol; 2015 Apr; 33(4):163.e1-6. PubMed ID: 25708953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radical Prostatectomy after Vascular Targeted Photodynamic Therapy with Padeliporfin: Feasibility, and Early and Intermediate Results.
    Pierrard V; Lebdai S; Kleinclauss F; Azzouzi AR; Terrier JE; Fortier E; Joniau S; Van Der Poel H; Salomon G; Casanova J; Medina-Lopez RA; Potiron E; Rigaud J; Vincendeau S; Rassweiler J; Villers A; Gaston R; Saussine C; Giai J; Gaillac B; Emberton M; Ruffion A
    J Urol; 2019 Feb; 201(2):315-321. PubMed ID: 30248343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utilization and impact of surgical technique on the performance of pelvic lymph node dissection at radical prostatectomy: Results from the Shared Equal Access Regional Cancer Hospital database.
    McGinley KF; Sun X; Howard LE; Aronson WJ; Terris MK; Kane CJ; Amling CL; Cooperberg MR; Freedland SJ
    Int J Urol; 2016 Mar; 23(3):241-6. PubMed ID: 26667212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and pathologic outcome after radical prostatectomy for prostate cancer patients with a preoperative Gleason sum of 8 to 10.
    Bastian PJ; Gonzalgo ML; Aronson WJ; Terris MK; Kane CJ; Amling CL; Presti JC; Mangold LA; Humphreys E; Epstein JI; Partin AW; Freedland SJ
    Cancer; 2006 Sep; 107(6):1265-72. PubMed ID: 16900523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perioperative Morbidity of Radical Prostatectomy After Intensive Neoadjuvant Androgen Blockade in Men With High-Risk Prostate Cancer: Results of Phase II Trial Compared to a Control Group.
    Ilario EN; Bastos DA; Guglielmetti GB; Murta CB; Cardili L; Cordeiro MD; Junior JP; Coelho RF; Nahas WC
    Clin Genitourin Cancer; 2023 Feb; 21(1):43-54. PubMed ID: 36428171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Work ability in prostate cancer survivors after radical prostatectomy.
    Dahl S; Cvancarova M; Dahl AA; Fosså SD
    Scand J Urol; 2016; 50(2):116-22. PubMed ID: 26609896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complications after open and robot-assisted radical prostatectomy and association with postoperative opioid use: an analysis of data from the PREVENTER trial.
    Huang MM; Su ZT; Becker REN; Pavlovich CP; Partin AW; Allaf ME; Patel HD
    BJU Int; 2021 Feb; 127(2):190-197. PubMed ID: 32654363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radical prostatectomy for clinical T4 prostate cancer.
    Johnstone PA; Ward KC; Goodman M; Assikis V; Petros JA
    Cancer; 2006 Jun; 106(12):2603-9. PubMed ID: 16700037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term follow-up of a neoadjuvant chemohormonal taxane-based phase II trial before radical prostatectomy in patients with non-metastatic high-risk prostate cancer.
    Prayer-Galetti T; Sacco E; Pagano F; Gardiman M; Cisternino A; Betto G; Sperandio P
    BJU Int; 2007 Aug; 100(2):274-80. PubMed ID: 17355369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors and rate of adjuvant radiation therapy following radical prostatectomy: A report from the Prostate Cancer Registry.
    Daniels CP; Millar JL; Spelman T; Sengupta S; Evans SM
    J Med Imaging Radiat Oncol; 2016 Apr; 60(2):247-54. PubMed ID: 26548940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radical prostatectomy vs radiation therapy and androgen-suppression therapy in high-risk prostate cancer.
    Westover K; Chen MH; Moul J; Robertson C; Polascik T; Dosoretz D; Katin M; Salenius S; D'Amico AV
    BJU Int; 2012 Oct; 110(8):1116-21. PubMed ID: 22540922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.